FDA-filed SPL labeling · retrieved through openFDA

Aripiprazole

Aripiprazole is an atypical antipsychotic used to treat schizophrenia, bipolar disorder, depression (as add-on therapy), autism-related irritability, and Tourette's disorder.

Brand names Abilify MyCiteAbilifyOpipzaAbilify MaintenaAristada +2 more
Drug class ⓘ Atypical Antipsychotic
Rx Forms 5 Routes Oral · Intramuscular
Dr. Brian Staiger, PharmD, BCPS
Reviewed by Last reviewed Jul 10, 2026
🧬 Where this information comes from Click to expand

The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 125 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →

At a glance
Linked label effectiveJan 29, 2025
Clinical labels in scope ⓘ125
AvailabilityRx
Earliest approval/marketing year ⓘ2002
FDA-listed product records ⓘ856
Boxed warningYes
How we combine label and product data →
✓No current FDA shortage listed · checked Sep 22, 2026 🚨Recall on record · 7
Other forms & routes:
Injection
⭐ Aripiprazole at a glance The quick version — the full detail is in the Patient Information Guide below.
💊
HelloPharmacist Editorial Team Bottom Line
Aripiprazole is a versatile atypical antipsychotic that helps balance brain chemistry across several serious mental health conditions. It comes with important warnings — especially for elderly patients with dementia and young people on antidepressant therapy — so close monitoring is essential, particularly when starting or adjusting the medication. Work closely with your prescriber, report any unusual mood changes or movements right away, and never stop or change your dose without guidance.
How we write & review this content — our editorial policy →
⚠️ FDA Boxed Warning — the FDA’s strongest safety alert ▾

Two serious risks carry a boxed warning — the FDA's strongest safety alert.

Risk 1 — Elderly patients with dementia: Older adults with dementia-related psychosis who take antipsychotic drugs have a higher risk of death. Aripiprazole oral solution is not approved for this use. If your loved one has dementia, this medication should not be prescribed for their psychosis symptoms.

Risk 2 — Suicidal thoughts in young people: Antidepressants, including when aripiprazole is used as an add-on to antidepressants, can increase the risk of suicidal thoughts and behavior in children, adolescents, and young adults. Anyone starting this type of therapy should be watched closely for new or worsening thoughts of suicide, unusual mood changes, or self-harm — especially in the first weeks. Family members and caregivers should stay alert and contact the prescriber right away if these signs appear.

Read the full warning on DailyMed →

📖 Aripiprazole: Patient Information Guide

A plain-language walkthrough of Aripiprazole — what it treats, how it works, how it’s taken, side effects, warnings and interactions. Tap any section to expand it.

🎯What it's used for▾

Aripiprazole treats a range of mental health and neurological conditions:

  • Schizophrenia — in adults and adolescents (ages 13–17)
  • Bipolar I Disorder — for acute manic and mixed episodes, alone or alongside lithium or valproate, in adults and children (ages 10–17)
  • Major Depressive Disorder (MDD) — as an add-on to antidepressant therapy in adults
  • Irritability associated with autistic disorder — in children and adolescents (ages 6–17)
  • Tourette's disorder — in children and adolescents (ages 6–18)
⚙️How it works▾

Aripiprazole is called an atypical antipsychotic because it works differently from older antipsychotic drugs. Rather than fully blocking dopamine signals in the brain, it acts as a partial agonist (partial activator) at dopamine D2 receptors and at serotonin 5-HT1A receptors — meaning it gently modulates these pathways rather than shutting them down completely. It also blocks serotonin 5-HT2A receptors. This combination is thought to help regulate mood, thinking, and behavior without some of the harsher effects of older medications.

The exact reason this mechanism helps in schizophrenia and bipolar mania is still not fully understood, but the balance of dopamine and serotonin activity is believed to be key.

💊How it's taken▾

Aripiprazole oral solution is taken by mouth, usually once a day. It can be taken with or without food — eating does not meaningfully affect how much of the drug is absorbed. The dose your prescriber chooses will depend on the condition being treated, your age, and other medications you may be taking.

  • Take it at the same time each day to keep levels steady
  • Do not increase or stop your dose without talking to your prescriber first
  • It can take up to two weeks to reach stable levels in your body, so give it time to work
🤒Side effects — in detail▾

The most commonly reported side effects vary by condition but can include:

  • Akathisia — a restless, compulsive need to move
  • Drowsiness or sedation
  • Tremor
  • Nausea or vomiting
  • Insomnia
  • Fatigue
  • Blurred vision
  • Constipation or drooling (more common in younger patients)

Serious reactions — including uncontrolled muscle movements (tardive dyskinesia), signs of very high blood sugar, or a high fever with muscle stiffness (neuroleptic malignant syndrome) — need immediate medical attention. Don't wait to call your doctor if these appear.

⚠️Warnings & precautions▾
  • Elderly patients with dementia: Aripiprazole is NOT approved for dementia-related psychosis. Using it in this population carries a higher risk of death and stroke.
  • Suicidal thoughts: When used alongside antidepressants, there is an increased risk of suicidal thinking in children, teens, and young adults. Monitor closely, especially early in treatment.
  • Tardive dyskinesia: Long-term use can cause uncontrolled repetitive movements — often of the face or limbs. Tell your doctor right away if you notice this.
  • Neuroleptic Malignant Syndrome (NMS): A rare but dangerous reaction — high fever, stiff muscles, confusion, irregular heartbeat. Requires emergency care.
  • Metabolic changes: Weight gain, higher blood sugar, and changes in cholesterol can occur. Your doctor may monitor these regularly.
  • Compulsive behaviors: Some people develop urges to gamble, overeat, or engage in other compulsive behaviors. This is a recognized medication effect — tell your doctor if it happens.
  • Dizziness on standing: Aripiprazole can lower blood pressure when you stand up quickly, increasing fall risk — especially in older adults.
🔀What it interacts with▾

Aripiprazole is processed by liver enzymes, so other medications that affect those enzymes can change how much aripiprazole stays in your system:

  • Strong CYP3A4 inhibitors (e.g., itraconazole, clarithromycin) — block the breakdown of aripiprazole, raising its levels; your dose may need to be halved
  • Strong CYP2D6 inhibitors (e.g., fluoxetine, paroxetine, quinidine) — similarly raise aripiprazole levels; dose reduction may be needed
  • Strong CYP3A4 inducers (e.g., carbamazepine, rifampin) — speed up breakdown of aripiprazole, lowering its levels; your dose may need to be increased
  • Blood pressure medications — aripiprazole can amplify their blood-pressure-lowering effect, increasing dizziness and fall risk
  • Benzodiazepines (e.g., lorazepam) — combining these increases sedation and the risk of a sudden blood pressure drop

This is not a complete list of interactions. Always talk with your doctor or pharmacist before starting, stopping, or changing any medication.

📋Before taking it▾
  • Allergy: Do not take aripiprazole if you have had any allergic reaction to it in the past
  • Dementia: This medication is not approved and not safe for elderly patients with dementia-related psychosis
  • Diabetes or blood sugar concerns: Aripiprazole can raise blood sugar; tell your doctor if you have diabetes or a family history of it
  • Heart or blood pressure conditions: Your doctor should know about any cardiovascular history — aripiprazole can cause blood pressure to drop when standing
  • Seizure history: Use with caution; aripiprazole may lower the seizure threshold
  • Low white blood cell counts: Tell your doctor if you've had this issue before — monitoring will be needed
  • Pregnancy: Babies exposed to aripiprazole late in pregnancy may have withdrawal symptoms after birth. A pregnancy registry exists to track outcomes (1-866-961-2388). Discuss the risks and benefits with your doctor.
  • Breastfeeding: Aripiprazole passes into breast milk. Watch your baby for signs of dehydration or poor weight gain.
🚑If you take too much▾

Taking too much aripiprazole can cause vomiting, extreme drowsiness, and tremor. More serious effects — including irregular heartbeat, seizures, low blood pressure, and loss of consciousness — have also been reported. If you think you or someone else has taken too much, call 911 or Poison Control right away. Activated charcoal given early may help reduce absorption, and heart monitoring may be needed.

📡Pharmacodynamics — effects in the body▾

Aripiprazole has a strong attraction to dopamine D2, D3 and serotonin 5-HT1A and 5-HT2A receptors in the brain, as well as moderate activity at several other dopamine, serotonin, alpha-1 adrenergic, and histamine receptors. Unlike many older antipsychotics, it has virtually no activity at muscarinic (acetylcholine) receptors — which helps explain why it tends to cause fewer dry mouth, constipation, and urinary side effects. Its activity at alpha-1 adrenergic receptors is why it can enhance the blood-pressure-lowering effect of certain medications.

🔬Pharmacokinetics — how your body processes it▾

Aripiprazole is well absorbed when taken by mouth and can be taken with or without food. It reaches peak levels in the blood within 3 to 5 hours and has a long half-life of about 75 hours, meaning it stays in the body for several days — which is why it is taken just once a day. It is broken down in the liver primarily through two enzymes, CYP2D6 and CYP3A4, and it takes about 14 days of regular dosing to reach stable, steady levels in the body. People who are naturally slow metabolizers of the CYP2D6 enzyme will clear aripiprazole more slowly and may need a lower dose.

📦How to store it▾

Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F) .

📄 Written from Aripiprazole’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Every point is grounded in that labeling — nothing is invented. How we use AI →

250

Supplements & herbs that interact with Aripiprazole

250 supplements and herbal products have documented interactions with Aripiprazole in the licensed clinical database we use. Most are manageable — but your pharmacist should know about everything you take, including vitamins and herbals.

Severity mix
  • Major · 17
  • Moderate · 194
  • Minor · 39
1,4-BUTANEDIOL Major ACTIVATED CHARCOAL Major AMERICAN HELLEBORE Major ARSENIC Major BEER Major CESIUM Major EPHEDRA Major GAMMA-HYDROXYBUTYRATE (GHB) Major +242 more
Every supplement checked against Aripiprazole — ranked by severity The full interaction hub: 17 major · 194 moderate · 39 minor · every one linked to its full report. Check Aripiprazole against your exact supplements

Educational information from a licensed clinical database (Natural Medicines) — see our data sources & update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.

🩺 Pharmacist Counseling Corner

Quick, plain-English answers to the questions patients ask most about Aripiprazole — the kind of thing our pharmacy team would talk through with you at the counter.

What exactly is aripiprazole used for — is it just for schizophrenia? ▾
Not at all — aripiprazole actually has several approved uses. It's prescribed for schizophrenia, manic or mixed episodes of Bipolar I Disorder, and as an add-on to antidepressants when depression isn't fully controlled. It's also approved for irritability related to autism in kids and teens, and for Tourette's disorder. Your prescriber chose it for a specific reason based on your situation, so it's worth asking them which of these applies to you.
How long does it take before I notice it working? ▾
It typically takes up to two weeks for aripiprazole to build up to stable levels in your body, so don't be discouraged if you don't feel a difference right away. For some conditions, you may start to notice gradual improvement within the first couple of weeks, but full benefit can take longer. Stick with it and keep your follow-up appointments so your prescriber can track how you're responding.
I've heard it can cause restlessness — what does that feel like, and what should I do? ▾
That's called akathisia, and it's one of the more common side effects. It feels like an inner sense of restlessness — a strong urge to keep moving, pace, or shift in your seat — that's hard to control. It's not dangerous, but it can be uncomfortable. If it's bothering you, tell your doctor; they may be able to adjust your dose or timing. Don't just stop taking the medication on your own.
Are there any medications I need to be careful about mixing with aripiprazole? ▾
Yes — a few important ones. Certain antifungals and antibiotics (like itraconazole or clarithromycin) and some antidepressants (like fluoxetine or paroxetine) can raise aripiprazole levels in your blood, which may mean you need a lower dose. On the flip side, medications like carbamazepine or rifampin can lower aripiprazole levels, possibly making it less effective. Blood pressure medications and sedatives like lorazepam can also interact. Always give your pharmacist a full list of everything you take — including over-the-counter products — before starting aripiprazole.
Is it safe to take during pregnancy or while breastfeeding? ▾
This is really a conversation to have with your doctor, because it's a balance of risks. Babies exposed to aripiprazole in the third trimester may have withdrawal symptoms or movement-related symptoms after birth. That said, untreated mental health conditions also carry real risks during pregnancy. If you become pregnant or are planning to, don't stop the medication abruptly — contact your prescriber right away. If you're breastfeeding, aripiprazole does pass into breast milk, so your baby should be watched for signs of dehydration or poor weight gain.
What warning signs should I never ignore while taking aripiprazole? ▾
A few things should prompt a call to your doctor or 911 right away. If you develop a high fever with stiff muscles and confusion, that could be a rare but serious reaction called neuroleptic malignant syndrome — get emergency help immediately. Any new uncontrolled movements, especially of your face or limbs, should also be reported right away. If you or someone you're caring for starts having thoughts of suicide or self-harm, call your doctor or a crisis line without delay. And if you notice unusual urges — like compulsive gambling or overeating — those can actually be a side effect of the medication, so tell your prescriber.
Is Aripiprazole available over the counter? ▾
Aripiprazole is dispensed by prescription according to its FDA labeling, so it isn't sold over the counter. Your prescriber and pharmacist will determine if it's appropriate for you.
When was Aripiprazole first available? ▾
Aripiprazole has been available in the United States since at least 2002, based on FDA approval history (Drugs@FDA) and product marketing records.
Who makes Aripiprazole? ▾
Aripiprazole is supplied by 88 manufacturers listed in the FDA NDC Directory, including Remedyrepack Inc., Bryant Ranch Prepack, Otsuka America Pharmaceutical, Inc..

💬 Answers drafted from Aripiprazole’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Grounded in that labeling — nothing is made up. How we use AI →

🧰 Keep exploring

📊Aripiprazole supplement interactions250 checked — ranked by severity 🌿Drug & Supplement CheckerAripiprazole vs. vitamins & herbs 💬Ask a PharmacistFree answer, usually < 24h 🔎NDC & pricing lookupFind Aripiprazole NDCs & costs 🅰️Browse Drugs A–ZLook up any medication

💊 How Aripiprazole comes

Aripiprazole is available in 5 forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.

Tablet

By mouth
Brands Abilify Abilify MyCite
Available strengths 6 strengths
2 mg 5 mg 10 mg 15 mg 20 mg 30 mg
706 FDA-listed product records ⓘ

Orally disintegrating tablet

By mouth
Available strengths 4 strengths
10 mg 15 mg 20 mg 30 mg
34 FDA-listed product records ⓘ

Oral solution

By mouth
Available strengths 1 strength
1 mg/mL
26 FDA-listed product records ⓘ

Dissolving oral film

By mouth
Brands Opipza
Available strengths 3 strengths
2 mg 5 mg 10 mg
3 FDA-listed product records ⓘ

📊 Aripiprazole across the U.S. market

How Aripiprazole appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.

5
Dose forms ⓘ
88
Manufacturers
8
Brand names
856
FDA-listed product records ⓘ
2002
First marketed ⓘ

FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

Also listed with the FDA, not a patient dose form: Powder (45) · Kit (12) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.

Remedyrepack Inc.9%
Bryant Ranch Prepack6%
Otsuka America Pharmaceutical, Inc.6%
Aurobindo Pharma Limited5%
Major Pharmaceuticals3%
A-S Medication Solutions3%
Other makers67%

Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

📈 How widely Aripiprazole is used

A general measure of how commonly Aripiprazole is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.

Think of this as a proxy for how widely Aripiprazole is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.

5,031,681
Medicaid prescriptions filled (Q1–Q4 2025)
$1.39B gross Medicaid reimbursement (before mandatory rebates — net cost is lower)

How commonly is Aripiprazole prescribed? Of the 1,596 medications we measure, Aripiprazole ranks #43 by Medicaid prescriptions — more than 97% of them.

Where Aripiprazole ranks among the drugs we measure · Q1–Q4 2025 · neighbors ±5
Total prescriptions — #43 of 1,596
#38 Prednisone 5,404,950 Rx #39 Montelukast 5,399,653 Rx #40 Azithromycin 5,254,152 Rx #41 Loratadine 5,204,681 Rx #42 Buspirone 5,180,004 Rx #43 Aripiprazole 5,031,681 Rx #44 Diclofenac Topical (ar... 4,673,607 Rx #45 Diclofenac Topical (ac... 4,673,607 Rx #46 Diclofenac 4,673,607 Rx #47 Lamotrigine 4,467,083 Rx #48 Cyclobenzaprine 4,437,147 Rx

Utilization by Aripiprazole product

Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.

The 5 mg oral tablet is the most-dispensed Aripiprazole product — about 29% of these Medicaid prescriptions.

aripiprazole 5 MG Oral Tablet Most dispensed

1,484,032 Medicaid prescriptions (Q1–Q4 2025) 29% of Aripiprazole prescriptions shown $19.9M gross reimbursement (before rebates) ≈ $13 per prescription (gross)

Summed across the 27 of 158 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 402131

aripiprazole 10 MG Oral Tablet

1,063,540 Medicaid prescriptions (Q1–Q4 2025) 21% of Aripiprazole prescriptions shown $15M gross reimbursement (before rebates) ≈ $14 per prescription (gross)

Summed across the 24 of 138 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 349545

aripiprazole 2 MG Oral Tablet

822,163 Medicaid prescriptions (Q1–Q4 2025) 16% of Aripiprazole prescriptions shown $11.6M gross reimbursement (before rebates) ≈ $14 per prescription (gross)

Summed across the 23 of 129 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 602964

aripiprazole 15 MG Oral Tablet

564,594 Medicaid prescriptions (Q1–Q4 2025) 11% of Aripiprazole prescriptions shown $8.3M gross reimbursement (before rebates) ≈ $15 per prescription (gross)

Summed across the 22 of 114 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 349490

aripiprazole 20 MG Oral Tablet

375,835 Medicaid prescriptions (Q1–Q4 2025) 7% of Aripiprazole prescriptions shown $7.1M gross reimbursement (before rebates) ≈ $19 per prescription (gross)

Summed across the 21 of 113 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 349553

2 ML aripiprazole 200 MG/ML Prefilled Syringe

202,287 Medicaid prescriptions (Q1–Q4 2025) 4% of Aripiprazole prescriptions shown $554.6M gross reimbursement (before rebates) ≈ $2,741 per prescription (gross)

Summed across the 1 of 2 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1602171

aripiprazole 30 MG Oral Tablet

194,024 Medicaid prescriptions (Q1–Q4 2025) 4% of Aripiprazole prescriptions shown $3.4M gross reimbursement (before rebates) ≈ $18 per prescription (gross)

Summed across the 19 of 91 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 349547

aripiprazole 400 MG Injection

54,067 Medicaid prescriptions (Q1–Q4 2025) 1% of Aripiprazole prescriptions shown $147.7M gross reimbursement (before rebates) ≈ $2,732 per prescription (gross)

Summed across the 2 of 5 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1659812

aripiprazole 1 MG/ML Oral Solution

51,581 Medicaid prescriptions (Q1–Q4 2025) 1% of Aripiprazole prescriptions shown $6.8M gross reimbursement (before rebates) ≈ $133 per prescription (gross)

Summed across the 7 of 15 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 485496

1.5 ML aripiprazole 200 MG/ML Prefilled Syringe

50,619 Medicaid prescriptions (Q1–Q4 2025) 1% of Aripiprazole prescriptions shown $104M gross reimbursement (before rebates) ≈ $2,055 per prescription (gross)

Summed across the 1 of 1 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1602163

3.2 ML aripiprazole 300 MG/ML Prefilled Syringe

25,862 Medicaid prescriptions (Q1–Q4 2025) <1% of Aripiprazole prescriptions shown $141M gross reimbursement (before rebates) ≈ $5,452 per prescription (gross)

Summed across the 1 of 2 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 2636645

aripiprazole 300 MG Injection

16,559 Medicaid prescriptions (Q1–Q4 2025) <1% of Aripiprazole prescriptions shown $33.8M gross reimbursement (before rebates) ≈ $2,044 per prescription (gross)

Summed across the 2 of 4 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1659816

2.4 ML aripiprazole 300 MG/ML Prefilled Syringe

5,444 Medicaid prescriptions (Q1–Q4 2025) <1% of Aripiprazole prescriptions shown $22.3M gross reimbursement (before rebates) ≈ $4,102 per prescription (gross)

Summed across the 1 of 1 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 2636637

aripiprazole 10 MG Disintegrating Oral Tablet

5,302 Medicaid prescriptions (Q1–Q4 2025) <1% of Aripiprazole prescriptions shown $851,894 gross reimbursement (before rebates) ≈ $161 per prescription (gross)

Summed across the 4 of 16 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 643019

aripiprazole 15 MG Disintegrating Oral Tablet

3,308 Medicaid prescriptions (Q1–Q4 2025) <1% of Aripiprazole prescriptions shown $568,128 gross reimbursement (before rebates) ≈ $172 per prescription (gross)

Summed across the 4 of 16 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 643022

aripiprazole 2 MG Oral Film

50 Medicaid prescriptions (Q2–Q4 2025) <1% of Aripiprazole prescriptions shown $94,949 gross reimbursement (before rebates) ≈ $1,899 per prescription (gross)

Summed across the 1 of 3 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 2697158

aripiprazole 5 MG Oral Film

34 Medicaid prescriptions (Q1–Q4 2025) <1% of Aripiprazole prescriptions shown $67,894 gross reimbursement (before rebates) ≈ $1,997 per prescription (gross)

Summed across the 1 of 3 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 2697165

aripiprazole 10 MG Oral Film

12 Medicaid prescriptions (Q1–Q4 2025) <1% of Aripiprazole prescriptions shown $25,813 gross reimbursement (before rebates) ≈ $2,151 per prescription (gross)

Summed across the 1 of 2 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 2697168

Other Aripiprazole products — combination packs and listings not yet matched to a specific clinical product (kept visible so every prescription is accounted for)

112,368 Medicaid prescriptions (Q1–Q4 2025) 2% of Aripiprazole prescriptions shown $309.7M gross reimbursement (before rebates) ≈ $2,756 per prescription (gross)

Summed across the 5 of 244 listed NDC products with Medicaid activity.

Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.

Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Aripiprazole, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 167 of 1,057 listed Aripiprazole NDCs with Medicaid activity.

🔍 Compare Aripiprazole products

A representative set of FDA-listed product records for Aripiprazole — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)

Showing 200 of 856 products — FDA National Drug Code Directory. See every product, package size and price: browse all 856 Aripiprazole NDCs →

RxNorm Concept Web — From Ingredient to Every Form and Strength

This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.

Ingredient (IN) Aripiprazole RxCUI 89013 6 dose forms · 27 strengths
  1. Dose form (SCDF) Disintegrating Oral Tablet RxCUI 643018 In current FDA listings
    Clinical drug / strength (SCD) 10 MG RxCUI 643019 15 MG RxCUI 643022 20 MG RxCUI 643027 30 MG RxCUI 643058
  2. Dose form (SCDF) Injection RxCUI 1659782 In current FDA listings
    Clinical drug / strength (SCD) 1.3 ML aripiprazole 7.5 MG/ML RxCUI 672356 300 MG RxCUI 1659816 400 MG RxCUI 1659812
  3. Dose form (SCDF) Oral Film RxCUI 2697157 In current FDA listings
    Clinical drug / strength (SCD) 2 MG RxCUI 2697158 5 MG RxCUI 2697165 10 MG RxCUI 2697168
  4. Dose form (SCDF) Oral Solution RxCUI 485495 In current FDA listings
    Clinical drug / strength (SCD) 1 MG/ML RxCUI 485496
  5. Dose form (SCDF) Oral Tablet RxCUI 378301 In current FDA listings
    Clinical drug / strength (SCD) Sensor aripiprazole 10 MG RxCUI 1998451 Sensor aripiprazole 15 MG RxCUI 1998454 Sensor aripiprazole 2 MG RxCUI 1998456 Sensor aripiprazole 20 MG RxCUI 1998458 Sensor aripiprazole 30 MG RxCUI 1998460 Sensor aripiprazole 5 MG RxCUI 1998462 2 MG RxCUI 602964 5 MG RxCUI 402131 10 MG RxCUI 349545 15 MG RxCUI 349490 20 MG RxCUI 349553 30 MG RxCUI 349547

Look up RxCUI 89013 in the RxCUI Atlas →

RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.

🏷️ Sold under these brand names

Abilify MyCite Abilify Opipza Abilify Maintena Aristada Abilify Asimtufii Aristada Initio

🏭 Manufacturers & labelers

Remedyrepack Inc. 64 Bryant Ranch Prepack 47 Otsuka America Pharmaceutical, Inc. 42 Aurobindo Pharma Limited 39 Major Pharmaceuticals 26 A-S Medication Solutions 25 Camber Pharmaceuticals, Inc. 25 ScieGen Pharmaceuticals Inc 24 XLCare Pharmaceuticals, Inc. 24 Solco Healthcare U.S., LLC 24 Alembic Pharmaceuticals Inc. 22 Amneal Pharmaceuticals LLC 21 Alkermes, Inc. 20 NorthStar RxLLC 19 Macleods Pharmaceuticals Limited 18 AvPAK 18 Accord Healthcare, Inc. 18 Ascend Laboratories, LLC 18 Otsuka Pharmaceutical Co., Ltd. 18 Unichem Pharmaceuticals (USA), Inc. 18 Ajanta Pharma USA Inc. 18 Torrent Pharmaceuticals Limited 18 American Health Packaging 18 Alembic Pharmaceuticals Limited 17

…and 16 more on the FDA NDC directory.

RxNorm drug class

Aripiprazole belongs to the Atypical Antipsychotic class.

Pharmacologic class Atypical Antipsychotic
Drug family (ATC) Other antipsychotics

Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.

🔬 Where this comes from

Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.

📄
FDA-filed drug labels (SPL) Uses, dosing, warnings & side effects from SPL records retrieved through openFDA; the linked representative set can be verified on DailyMed. ✓ Linked label effective Jan 29, 2025
🏭
Forms, brands & labelersAggregated from ingredient-matched FDA National Drug Code Directory product records for Aripiprazole.
📈
Real-world reportsThe FDA Adverse Event Reporting System (FAERS), served through openFDA.
🚨
Recalls & shortagesopenFDA drug-enforcement reports and the FDA drug-shortage database.
🧾 Clinical label set — FDA-filed SPL labels retained for Aripiprazole after exact ingredient or ingredient-combination matching and applicable route/form matching
Clinical labels in scope
125
NDC products indexed
856
Distinct labelers/manufacturers represented
88
Linked representative label ⓘ
Otsuka America Pharmaceutical, Inc.
Linked label effective
Jan 29, 2025
Composite sections available
26
Linked SPL Set ID
c040bd1d-45b7-49f2-93ea-aed7220b30ac
Linked SPL Document ID
1b189d15-798d-4bed-a93d-a543ed7abd81
Open the linked representative label on DailyMed ↗

How we combine label and product data

HelloPharmacist combines public FDA and NLM records; we don’t author the underlying clinical facts. We identified 125 FDA-filed SPL label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. The representative label is the starting point for the displayed reference monograph; the 12 largest stored in-scope SPL records, which may include that representative, are compared section by section, and the longest available version of each section is retained. Forms, routes, brands, labelers, product-listed strengths, and product-record counts are aggregated separately from ingredient-matched FDA NDC Directory records; package records listed above are associated with the linked SPL; and the normalized concept hierarchy comes from NLM RxNorm.

For canonical ingredient pages, bounded product-attributed indication and administration excerpts may be added to the AI evidence, and the generator is instructed to preserve available product, brand, route, and form qualifiers instead of treating one label as universal. Where a section is identified as AI-written, its plain-language text is generated from bounded label evidence. New draft drug pages remain in the admin review queue before first publication. Otsuka America Pharmaceutical, Inc. is the representative DailyMed label linked for verification and dates; it is not the sole source used for the page.

This is general education, not medical advice — always consult your doctor or pharmacist about your medications and any medical condition. For the exact wording of the linked representative label, view that label on DailyMed; some displayed composite sections may come from other in-scope SPL labels. Learn how we use AI and our data sources & update cadence.